why choose us

First received: May 19, 2023

Clinical Trial: Adaptive Radiation for Abdominopelvic Metastases

Study Status: Completed

Recruit Status: RECRUITING

Condition: Neoplasm - Soft Tissue Pelvis Malignant Secondary

Study Type: INTERVENTIONAL


Official Title: Adaptive Radiation for Abdominopelvic Metastases (ARAM)

Brief Summary: Single arm Phase I trial of adaptive stereotactic body radiation (SBRT) for abdominopelvic metastases.Adaptive SBRT will allow for escalation of the prescription dose and target coverage while maintaining grade 3+ toxicity no greater than 10%.Subjects with metastatic cancer to the abdomen or pelvis requiring local control or palliation will be enrolled.

Read more